Kirkland Represents CoverMyMeds on Sale to McKesson Corporation

Kirkland & Ellis LLP advised CoverMyMeds, LLC, one of the fastest growing healthcare technology companies in the U.S., on its sale to McKesson Corporation (NYSE:MCK), a healthcare services and information technology company, for approximately $1.1 billion plus contingent consideration of up to $0.3 billion.  The transaction is subject to customary closing conditions, including regulatory review, and is expected to close in the first half of Fiscal 2018.  Further details can be found here.

The Kirkland team was led by corporate partners Adam Phillips and Lilit Voskanyan, intellectual property partners Gianni Cutri and John Lynn, tax partner Keith Villmow; antitrust partner Ian John, and executive compensation partner Scott Price.